Get started
CryoPort, Inc.CryoPort, Inc.CryoPort, Inc.

CryoPort, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

CYRX chart


Full chart

CYRX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪280.00 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.49 USD
Net income (FY)
‪−114.76 M‬ USD
Revenue (FY)
‪228.38 M‬ USD
Shares float
‪48.07 M‬
Beta (1Y)
0.72

Employees


Employees (FY)
‪1.19 K‬
Change (1Y)
+16 +1.37%
Revenue / Employee (1Y)
‪192.57 K‬ USD
Net income / Employee (1Y)
‪−96.76 K‬ USD

About CryoPort, Inc.


Sector
Transportation
Industry
Air Freight/Couriers
CEO
Jerrell W. Shelton
Website
cryoport.com
Headquarters
Brentwood
Founded
1990
FIGI
BBG000PNTXP0
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CYRX news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as CYRX.

Frequently Asked Questions


The current price of CYRX is 5.55 USD — it has decreased by −2.50% in the past 24 hours. Watch CryoPort, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CryoPort, Inc. stocks are traded under the ticker CYRX.
CYRX stock has risen by 2.05% compared to the previous week, the month change is a −14.93% fall, over the last year CryoPort, Inc. has showed a −67.71% decrease.
We've gathered analysts' opinions on CryoPort, Inc. future price: according to them, CYRX price has a max estimate of 15.00 USD and a min estimate of 6.50 USD. Watch CYRX chart and read a more detailed CryoPort, Inc. stock forecast: see what analysts think of CryoPort, Inc. and suggest that you do with its stocks.
CYRX reached its all-time high on Nov 22, 2005 with the price of 768.31 USD, and its all-time low was 1.03 USD and was reached on Feb 9, 2016. View more price dynamics on CYRX chart.
See other stocks reaching their highest and lowest prices.
CYRX stock is 4.24% volatile and has beta coefficient of 0.72. Track CryoPort, Inc. stock price on the chart and check out the list of the most volatile stocks — is CryoPort, Inc. there?
Today CryoPort, Inc. has the market capitalization of ‪280.00 M‬, it has increased by 4.85% over the last week.
Yes, you can track CryoPort, Inc. financials in yearly and quarterly reports right on TradingView.
CryoPort, Inc. is going to release the next earnings report on May 1, 2025. Keep track of upcoming events with our Earnings Calendar.
CYRX earnings for the last quarter are −0.42 USD per share, whereas the estimation was −0.29 USD resulting in a −43.43% surprise. The estimated earnings for the next quarter are −0.31 USD per share. See more details about CryoPort, Inc. earnings.
CryoPort, Inc. revenue for the last quarter amounts to ‪59.53 M‬ USD, despite the estimated figure of ‪58.50 M‬ USD. In the next quarter, revenue is expected to reach ‪58.83 M‬ USD.
CYRX net income for the last quarter is ‪−18.68 M‬ USD, while the quarter before that showed ‪805.00 K‬ USD of net income which accounts for ‪−2.42 K‬% change. Track more CryoPort, Inc. financial stats to get the full picture.
No, CYRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 18, 2025, the company has ‪1.19 K‬ employees. See our rating of the largest employees — is CryoPort, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CryoPort, Inc. EBITDA is ‪−35.60 M‬ USD, and current EBITDA margin is −16.31%. See more stats in CryoPort, Inc. financial statements.
Like other stocks, CYRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CryoPort, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CryoPort, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CryoPort, Inc. stock shows the sell signal. See more of CryoPort, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.